Cargando…
New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren’s syndrome: clinical efficacy, symptom relief, and improvement in quality of life
BACKGROUND: Patients with Sjögren’s syndrome (SS) typically present clinically with xerostomia (dry mouth) because of progressive damage to the exocrine glands. We developed a new, low-dose pilocarpine/sodium alginate (LPA) solution with pilocarpine hydrochloride to inhibit systemic adverse effects...
Autores principales: | Watanabe, Machiko, Yamada, Chisato, Komagata, Yoshinori, Kikuchi, Hirotoshi, Hosono, Hiroyuki, Itagaki, Fumio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831212/ https://www.ncbi.nlm.nih.gov/pubmed/29507747 http://dx.doi.org/10.1186/s40780-018-0099-x |
Ejemplares similares
-
P40 Dry eyes and a dry mouth: is it Sjögren’s syndrome?
por: Sen, Ethan S, et al.
Publicado: (2022) -
An Update on the Lived Experience of Dry Mouth in Sjögren's Syndrome Patients
por: Ngo, Di Ying Joanna, et al.
Publicado: (2021) -
Enhancement or Suppression of ACE Inhibitory Activity by a Mixture of Tea and Foods for Specified Health Uses (FOSHU) That Are Marketed as “Support for Normal Blood Pressure”
por: Murakami, Isao, et al.
Publicado: (2011) -
The influence of dietary peptide inhibitors of angiotensin-converting enzyme on the hypotensive effects of enalapril
por: Watanabe, Machiko, et al.
Publicado: (2015) -
Dysbiotic salivary microbiota in dry mouth and primary Sjögren’s syndrome patients
por: Rusthen, S., et al.
Publicado: (2019)